RZLT · Rezolute Inc
United States · RS rating 47 · As of 2026-11-03
| Price | 4.01 USD |
|---|---|
| 1-day change | +3.4% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 40 / 38 / 18 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 25 / 28 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -22.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +63.4% |
| Market cap (USD) | $297.6M |